Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2020
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohortAlessandro Soria, Marco Fava, Davide P Bernasconi, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Hepatology (Baltimore, Md.)|October 16, 2025
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 11